CGON

CG Oncology, Inc. Common stock (CGON)

US
$ 26.30.42%

Price Chart

Key Statistics

Market Cap
$ 1.97B
P/E Ratio
0.00
Revenue (TTM)
$ 662K
Volume
651.13K
52W High
$ 40.47
52W Low
$ 14.80
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
25.9432
200-Day MA
28.9774
52 Week High
40.47
52 Week Low
14.8

About CGON

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

Employees
113
Headquarters
Irvine, CA
CEO
Mr. Arthur Kuan

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96